Idiopathic Dilated Cardiomyopathy
Conditions
Interventions
Myocardial fibrosis will be assessed by cardiac MRI in patients with idiopathic dilated cardiomyopathy at the beginning of enrollment and at 2 and 5 years after enrollment. In addition, the presence o
Sponsors
St. Marianna University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 years and older 2. Diagnosed with idiopathic dilated cardiomyopathy 3. Subjects who have undergone cardiac MRI to evaluate myocardial fibrosis (within 1 month from the time of enrollment)
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to MRI examinations. 2. Patients with a history of serious allergic reactions to previous contrast CT or MRI examinations. 3. Patients with reduced systolic function that cannot be ruled out concerning coronary artery disease. 4. Patients with hypertrophic cardiomyopathy. 5. Patients with arrhythmogenic right ventricular cardiomyopathy. 6. Patients with valvular cardiomyopathy. 7. Patients with primary congenital heart disease (excluding cardiomyopathy). 8. Patients with acute myocarditis. 9. Patients not reasonably expected to survive longer than 1 year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of longitudinal changes in cardiac function and myocardial fibrosis in idiopathic dilated cardiomyopathy | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality, cardiovascular event rate, treatment, presence of genetic abnormalities, and their association with changes in cardiac function and myocardial fibrosis overtime during the observation period. | — |
Countries
Japan
Contacts
Public ContactIkutaro Nakajima
St. Marianna University School of Medicine Department of Cardiology
Outcome results
None listed